Circulating exosomal microRNA‐96 promotes cell proliferation, migration and drug resistance by targeting LMO7

Detection and treatment of lung cancer still remain a clinical challenge. This study aims to validate exosomal microRNA‐96 (miR‐96) as a serum biomarker for lung cancer and understand the underlying mechanism in lung cancer progression. MiR‐96 expressions in normal and lung cancer patients were char...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Zhou, Jingcheng, Mei, Shanshan, Wu, Da, Mu, Zhimin, Chen, Baokun, Xie, Yuancai, Ye, Yiwang, Liu, Jixian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431139/
https://www.ncbi.nlm.nih.gov/pubmed/28026121
http://dx.doi.org/10.1111/jcmm.13056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431139/
https://www.ncbi.nlm.nih.gov/pubmed/28026121
http://dx.doi.org/10.1111/jcmm.13056

Ejemplares similares